Identification and validation of critical genes with prognostic value in gastric cancer
Background: Gastric cancer (GC) is a digestive system tumor with high morbidity and mortality rates. Molecular targeted therapies, including those targeting human epidermal factor receptor 2 (HER2), have proven to be effective in clinical treatment. However, better identification and description of...
Main Authors: | Ningxin Dong, Xiaolong Ma, Jing Shen, Yunlu Zheng, Guiyuan Li, Shaoqiang Zheng, Xiaoyi Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.1072062/full |
Similar Items
-
MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner
by: Shenghe Deng, et al.
Published: (2023-11-01) -
Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC
by: Ce Li, et al.
Published: (2023-09-01) -
A Novel Six Metastasis-Related Prognostic Gene Signature for Patients With Osteosarcoma
by: Di Zheng, et al.
Published: (2021-07-01) -
MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial–Mesenchymal Transition In Gastric Cancer
by: Li T, et al.
Published: (2019-11-01) -
The biological role of extracellular vesicles in gastric cancer metastasis
by: Yun Lei, et al.
Published: (2024-01-01)